null

MRPL46 Rabbit Polyclonal Antibody (CAB15428)

SKU:
CAB15428
Product Type:
Antibody
Reactivity:
Human
Mouse
Host Species:
Rabbit
Isotype:
IgG
Antibody Type:
Polyclonal Antibody
Research Area:
Epigenetics and Nuclear Signaling
  • Epigenetics and Nuclear Signaling Antibodies 2 Anti-MRPL46 Antibody CAB15428
  • Epigenetics and Nuclear Signaling Antibodies 2 Anti-MRPL46 Antibody CAB15428
  • Epigenetics and Nuclear Signaling Antibodies 2 Anti-MRPL46 Antibody CAB15428
  • Epigenetics and Nuclear Signaling Antibodies 2 Anti-MRPL46 Antibody CAB15428
€139 - €419
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

MRPL46 Rabbit Polyclonal Antibody (CAB15428)

The MRPL46 Polyclonal Antibody (CAB15428) is a valuable tool for researchers studying mitochondrial ribosomal protein L46 (MRPL46) and its role in protein synthesis within the mitochondria. This antibody, produced in rabbits, exhibits high specificity for human samples and has been validated for use in Western blot applications. By targeting the MRPL46 protein, this antibody enables precise detection and analysis in various cell types, making it ideal for studies focused on mitochondrial function, cellular metabolism, and diseases associated with mitochondrial dysfunction.MRPL46 is a key component of the mitochondrial ribosome, which is responsible for synthesizing proteins essential for mitochondrial function. Dysregulation of MRPL46 expression or function has been linked to various human diseases, including mitochondrial disorders, cancer, and metabolic disorders.

By investigating the role of MRPL46 in these diseases, researchers can gain valuable insights into pathogenic mechanisms and potentially identify new therapeutic targets for intervention.Overall, the MRPL46 Polyclonal Antibody (CAB15428) offers researchers a reliable tool for exploring the complex role of MRPL46 in mitochondrial protein synthesis and its impact on cellular health and disease. Its specificity and sensitivity make it a valuable asset for studies aiming to uncover the molecular mechanisms underlying mitochondrial-related disorders and develop innovative treatments targeting mitochondrial dysfunction.